Characterization of four Escherichia albertii isolates collected from animals living in Antarctica and Patagonia
Jazyk angličtina Země Japonsko Médium print-electronic
Typ dokumentu časopisecké články
PubMed
29249728
PubMed Central
PMC5797873
DOI
10.1292/jvms.17-0492
Knihovny.cz E-zdroje
- Klíčová slova
- Antarctica, Escherichia albertii, bacteriocins, cytolethal distending toxin,
- MeSH
- Charadriiformes mikrobiologie MeSH
- Escherichia genetika izolace a purifikace metabolismus MeSH
- feces mikrobiologie MeSH
- multilokusová sekvenční typizace veterinární MeSH
- polymerázová řetězová reakce veterinární MeSH
- pulzní gelová elektroforéza veterinární MeSH
- ribotypizace veterinární MeSH
- RNA ribozomální 16S genetika MeSH
- Spheniscidae mikrobiologie MeSH
- tuleňovití mikrobiologie MeSH
- zvířata MeSH
- Check Tag
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Antarktida MeSH
- Chile MeSH
- Názvy látek
- RNA ribozomální 16S MeSH
Escherichia albertii is a recently discovered species with a limited number of well characterized strains. The aim of this study was to characterize four of the E. albertii strains, which were among 41 identified Escherichia strains isolated from the feces of living animals on James Ross Island, Antarctica, and Isla Magdalena, Patagonia. Sequencing of 16S rDNA, automated ribotyping, and rep-PCR were used to identify the four E. albertii isolates. Phylogenetic analyses based on multi-locus sequence typing showed these isolates to be genetically most similar to the members of E. albertii phylogroup G3. These isolates encoded several virulence factors including those, which are characteristic of E. albertii (cytolethal distending toxin and intimin) as well as bacteriocin determinants that typically have a very low prevalence in E. coli strains (D, E7). Moreover, E. albertii protein extracts caused cell cycle arrest in human cell line A375, probably because of cytolethal distending toxin activity.
Zobrazit více v PubMed
Albert M. J., Alam K., Islam M., Montanaro J., Rahaman A. S., Haider K., Hossain M. A., Kibriya A. K., Tzipori S.1991. Hafnia alvei, a probable cause of diarrhea in humans. Infect. Immun. 59: 1507–1513. PubMed PMC
Asoshima N., Matsuda M., Shigemura K., Honda M., Yoshida H., Oda T., Hiwaki H.2015. Isolation of Escherichia albertii from Raw Chicken Liver in Fukuoka City, Japan. Jpn. J. Infect. Dis. 68: 248–250. doi: 10.7883/yoken.JJID.2014.530 PubMed DOI
Asoshima N., Matsuda M., Shigemura K., Honda M., Yoshida H., Hiwaki H., Ogata K., Oda T.2014. Identification of Escherichia albertii as a causative agent of a food-borne outbreak occurred in 2003. Jpn. J. Infect. Dis. 67: 139–140. doi: 10.7883/yoken.67.139 PubMed DOI
Bezine E., Vignard J., Mirey G.2014. The cytolethal distending toxin effects on Mammalian cells: a DNA damage perspective. Cells 3: 592–615. doi: 10.3390/cells3020592 PubMed DOI PMC
Birosová E., Siegfried L., Kmet’ová M., Makara A., Ostró A., Gresová A., Urdzík P., Liptáková A., Molokácová M., Bártl R., Valanský L.2004. Detection of virulence factors in alpha-haemolytic Escherichia coli strains isolated from various clinical materials. Clin. Microbiol. Infect. 10: 569–573. doi: 10.1111/j.1469-0691.2004.00922.x PubMed DOI
Brandal L. T., Tunsjø H. S., Ranheim T. E., Løbersli I., Lange H., Wester A. L.2015. Shiga toxin 2a in Escherichia albertii. J. Clin. Microbiol. 53: 1454–1455. doi: 10.1128/JCM.03378-14 PubMed DOI PMC
Budič M., Rijavec M., Petkovšek Z., Zgur-Bertok D.2011. Escherichia coli bacteriocins: antimicrobial efficacy and prevalence among isolates from patients with bacteraemia. PLoS One 6: e28769. doi: 10.1371/journal.pone.0028769 PubMed DOI PMC
Comayras C., Tasca C., Pérès S. Y., Ducommun B., Oswald E., De Rycke J.1997. Escherichia coli cytolethal distending toxin blocks the HeLa cell cycle at the G2/M transition by preventing cdc2 protein kinase dephosphorylation and activation. Infect. Immun. 65: 5088–5095. PubMed PMC
Felföldi T., Heéger Z., Vargha M., Márialigeti K.2010. Detection of potentially pathogenic bacteria in the drinking water distribution system of a hospital in Hungary. Clin. Microbiol. Infect. 16: 89–92. doi: 10.1111/j.1469-0691.2009.02795.x PubMed DOI
Fiedoruk K., Daniluk T., Swiecicka I., Murawska E., Sciepuk M., Leszczynska K.2014. First Complete Genome Sequence of Escherichia albertii Strain KF1, a New Potential Human Enteric Pathogen. Genome Announc. 2: 2. doi: 10.1128/genomeA.00004-14 PubMed DOI PMC
Gillor O., Giladi I., Riley M. A.2009. Persistence of colicinogenic Escherichia coli in the mouse gastrointestinal tract. BMC Microbiol. 9: 165. doi: 10.1186/1471-2180-9-165 PubMed DOI PMC
Gordon D. M., O’Brien C. L.2006. Bacteriocin diversity and the frequency of multiple bacteriocin production in Escherichia coli. Microbiology 152: 3239–3244. doi: 10.1099/mic.0.28690-0 PubMed DOI
Hinenoya A., Yasuda N., Hibino T., Shima A., Nagita A., Tsukamoto T., Yamasaki S.2017. Isolation and Characterization of an Escherichia albertii Strain Producing Three Different Toxins from a Child with Diarrhea. Jpn. J. Infect. Dis. 70: 252–257. doi: 10.7883/yoken.JJID.2016.186 PubMed DOI
Hinenoya A., Shima K., Asakura M., Nishimura K., Tsukamoto T., Ooka T., Hayashi T., Ramamurthy T., Faruque S. M., Yamasaki S.2014. Molecular characterization of cytolethal distending toxin gene-positive Escherichia coli from healthy cattle and swine in Nara, Japan. BMC Microbiol. 14: 97. doi: 10.1186/1471-2180-14-97 PubMed DOI PMC
Huys G., Cnockaert M., Janda J. M., Swings J.2003. Escherichia albertii sp. nov., a diarrhoeagenic species isolated from stool specimens of Bangladeshi children. Int. J. Syst. Evol. Microbiol. 53: 807–810. doi: 10.1099/ijs.0.02475-0 PubMed DOI
Hyma K. E., Lacher D. W., Nelson A. M., Bumbaugh A. C., Janda J. M., Strockbine N. A., Young V. B., Whittam T. S.2005. Evolutionary genetics of a new pathogenic Escherichia species: Escherichia albertii and related Shigella boydii strains. J. Bacteriol. 187: 619–628. doi: 10.1128/JB.187.2.619-628.2005 PubMed DOI PMC
Inglis T. J. J., Merritt A. J., Bzdyl N., Lansley S., Urosevic M. N.2015. First bacteraemic human infection with Escherichia albertii. New Microbes New Infect. 8: 171–173. doi: 10.1016/j.nmni.2015.07.003 PubMed DOI PMC
Kohoutová D., Šmajs D., Morávková P., Cyrany J., Morávková M., Forstlová M., Cihák M., Rejchrt S., Bureš J.2014. Escherichia coli strains of phylogenetic group B2 and D and bacteriocin production are associated with advanced colorectal neoplasia. BMC Infect. Dis. 14: 733. doi: 10.1186/s12879-014-0733-7 PubMed DOI PMC
Kuhnert P., Hacker J., Mühldorfer I., Burnens A. P., Nicolet J., Frey J.1997. Detection system for Escherichia coli-specific virulence genes: absence of virulence determinants in B and C strains. Appl. Environ. Microbiol. 63: 703–709. PubMed PMC
La Ragione R. M., McLaren I. M., Foster G., Cooley W. A., Woodward M. J.2002. Phenotypic and genotypic characterization of avian Escherichia coli O86:K61 isolates possessing a gamma-like intimin. Appl. Environ. Microbiol. 68: 4932–4942. doi: 10.1128/AEM.68.10.4932-4942.2002 PubMed DOI PMC
Lindsey R. L., Fedorka-Cray P. J., Abley M., Turpin J. B., Meinersmann R. J.2015. Evaluating the occurrence of Escherichia albertii in chicken carcass rinses by PCR, Vitek analysis, and sequencing of the rpoB gene. Appl. Environ. Microbiol. 81: 1727–1734. doi: 10.1128/AEM.03681-14 PubMed DOI PMC
López-Saucedo C., Cerna J. F., Villegas-Sepulveda N., Thompson R., Velazquez F. R., Torres J., Tarr P. I., Estrada-García T.2003. Single multiplex polymerase chain reaction to detect diverse loci associated with diarrheagenic Escherichia coli. Emerg. Infect. Dis. 9: 127–131. doi: 10.3201/eid0901.010507 PubMed DOI PMC
Luo C., Walk S. T., Gordon D. M., Feldgarden M., Tiedje J. M., Konstantinidis K. T.2011. Genome sequencing of environmental Escherichia coli expands understanding of the ecology and speciation of the model bacterial species. Proc. Natl. Acad. Sci. U.S.A. 108: 7200–7205. doi: 10.1073/pnas.1015622108 PubMed DOI PMC
Maeda E., Murakami K., Sera N., Ito K., Fujimoto S.2015. Detection of Escherichia albertii from chicken meat and giblets. J. Vet. Med. Sci. 77: 871–873. doi: 10.1292/jvms.14-0640 PubMed DOI PMC
Maheux A. F., Boudreau D. K., Bergeron M. G., Rodriguez M. J.2014. Characterization of Escherichia fergusonii and Escherichia albertii isolated from water. J. Appl. Microbiol. 117: 597–609. doi: 10.1111/jam.12551 PubMed DOI
Martínez J. L., Herrero M., de Lorenzo V.1994. The organization of intercistronic regions of the aerobactin operon of pColV-K30 may account for the differential expression of the iucABCD iutA genes. J. Mol. Biol. 238: 288–293. doi: 10.1006/jmbi.1994.1290 PubMed DOI
Micenková L., Bosák J., Vrba M., Ševčíková A., Šmajs D.2016. Human extraintestinal pathogenic Escherichia coli strains differ in prevalence of virulence factors, phylogroups, and bacteriocin determinants. BMC Microbiol. 16: 218. doi: 10.1186/s12866-016-0835-z PubMed DOI PMC
Micenková L., Beňová A., Frankovičová L., Bosák J., Vrba M., Ševčíková A., Kmeťová M., Šmajs D.2017. Human Escherichia coli isolates from hemocultures: Septicemia linked to urogenital tract infections is caused by isolates harboring more virulence genes than bacteraemia linked to other conditions. Int. J. Med. Microbiol. 307: 182–189. doi: 10.1016/j.ijmm.2017.02.003 PubMed DOI
Micenková L., Štaudová B., Bosák J., Mikalová L., Littnerová S., Vrba M., Ševčíková A., Woznicová V., Šmajs D.2014. Bacteriocin-encoding genes and ExPEC virulence determinants are associated in human fecal Escherichia coli strains. BMC Microbiol. 14: 109. doi: 10.1186/1471-2180-14-109 PubMed DOI PMC
Micenková L., Bosák J., Štaudová B., Kohoutová D., Čejková D., Woznicová V., Vrba M., Ševčíková A., Bureš J., Šmajs D.2016. Microcin determinants are associated with B2 phylogroup of human fecal Escherichia coli isolates. MicrobiologyOpen 5: 490–498. doi: 10.1002/mbo3.345 PubMed DOI PMC
Morato E. P., Leomil L., Beutin L., Krause G., Moura R. A., Pestana de Castro A. F.2009. Domestic cats constitute a natural reservoir of human enteropathogenic Escherichia coli types. Zoonoses Public Health 56: 229–237. doi: 10.1111/j.1863-2378.2008.01190.x PubMed DOI
Nimri L. F.2013. Escherichia albertii, a newly emerging enteric pathogen with poorly defined properties. Diagn. Microbiol. Infect. Dis. 77: 91–95. doi: 10.1016/j.diagmicrobio.2013.06.028 PubMed DOI
Oaks J. L., Besser T. E., Walk S. T., Gordon D. M., Beckmen K. B., Burek K. A., Haldorson G. J., Bradway D. S., Ouellette L., Rurangirwa F. R., Davis M. A., Dobbin G., Whittam T. S.2010. Escherichia albertii in wild and domestic birds. Emerg. Infect. Dis. 16: 638–646. doi: 10.3201/eid1604.090695 PubMed DOI PMC
Oh J. Y., Kang M. S., Hwang H. T., An B. K., Kwon J. H., Kwon Y. K.2011. Epidemiological investigation of eaeA-positive Escherichia coli and Escherichia albertii strains isolated from healthy wild birds. J. Microbiol. 49: 747–752. doi: 10.1007/s12275-011-1133-y PubMed DOI
Ooka T., Tokuoka E., Furukawa M., Nagamura T., Ogura Y., Arisawa K., Harada S., Hayashi T.2013. Human gastroenteritis outbreak associated with Escherichia albertii, Japan. Emerg. Infect. Dis. 19: 144–146. doi: 10.3201/eid1901.120646 PubMed DOI PMC
Ooka T., Seto K., Kawano K., Kobayashi H., Etoh Y., Ichihara S., Kaneko A., Isobe J., Yamaguchi K., Horikawa K., Gomes T. A. T., Linden A., Bardiau M., Mainil J. G., Beutin L., Ogura Y., Hayashi T.2012. Clinical significance of Escherichia albertii. Emerg. Infect. Dis. 18: 488–492. doi: 10.3201/eid1803.111401 PubMed DOI PMC
Ooka T., Ogura Y., Katsura K., Seto K., Kobayashi H., Kawano K., Tokuoka E., Furukawa M., Harada S., Yoshino S., Seto J., Ikeda T., Yamaguchi K., Murase K., Gotoh Y., Imuta N., Nishi J., Gomes T. A., Beutin L., Hayashi T.2015. Defining the Genome Features of Escherichia albertii, an Emerging Enteropathogen Closely Related to Escherichia coli. Genome Biol. Evol. 7: 3170–3179. PubMed PMC
Paciorek J.2002. Virulence properties of Escherichia coli faecal strains isolated in Poland from healthy children and strains belonging to serogroups O18, O26, O44, O86, O126 and O127 isolated from children with diarrhoea. J. Med. Microbiol. 51: 548–556. doi: 10.1099/0022-1317-51-7-548 PubMed DOI
Paton A. W., Paton J. C.1998. Detection and characterization of Shiga toxigenic Escherichia coli by using multiplex PCR assays for stx1, stx2, eaeA, enterohemorrhagic E. coli hlyA, rfbO111, and rfbO157. J. Clin. Microbiol. 36: 598–602. PubMed PMC
Pickett C. L., Cottle D. L., Pesci E. C., Bikah G.1994. Cloning, sequencing, and expression of the Escherichia coli cytolethal distending toxin genes. Infect. Immun. 62: 1046–1051. PubMed PMC
Pontes D. S., Pinheiro F. A., Lima-Bittencourt C. I., Guedes R. L. M., Cursino L., Barbosa F., Santos F. R., Chartone-Souza E., Nascimento A. M. A.2009. Multiple antimicrobial resistance of gram-negative bacteria from natural oligotrophic lakes under distinct anthropogenic influence in a tropical region. Microb. Ecol. 58: 762–772. doi: 10.1007/s00248-009-9539-3 PubMed DOI
Rahman M. Z., Akter S., Azmuda N., Sultana M., Weill F. X., Khan S. I., Grimont P. A. D., Birkeland N. K.2013. Serological cross-reaction between O-antigens of Shigella dysenteriae type 4 and an environmental Escherichia albertii isolate. Curr. Microbiol. 67: 590–595. doi: 10.1007/s00284-013-0405-7 PubMed DOI
Schmidt H., Knop C., Franke S., Aleksic S., Heesemann J., Karch H.1995. Development of PCR for screening of enteroaggregative Escherichia coli. J. Clin. Microbiol. 33: 701–705. PubMed PMC
Sedláček I., Grillová L., Kroupová E., Černohlávková J., Šmajs D.2013. Escherichia albertii from feces of seals (Leptonychotes weddelli) in James Ross Island, Antarctica. Czech Polar Reports 3: 173–183. doi: 10.5817/CPR2013-2-18 DOI
Sharma M., Kniel K. E., Derevianko A., Ling J., Bhagwat A. A.2007. Sensitivity of Escherichia albertii, a potential food-borne pathogen, to food preservation treatments. Appl. Environ. Microbiol. 73: 4351–4353. doi: 10.1128/AEM.03001-06 PubMed DOI PMC
Shima A., Hinenoya A., Asakura M., Sugimoto N., Tsukamoto T., Ito H., Nagita A., Faruque S. M., Yamasaki S.2012. Molecular characterizations of cytolethal distending toxin produced by Providencia alcalifaciens strains isolated from patients with diarrhea. Infect. Immun. 80: 1323–1332. doi: 10.1128/IAI.05831-11 PubMed DOI PMC
Slaninová I., Brezinová L., Koubíková L., Slanina J.2009. Dibenzocyclooctadiene lignans overcome drug resistance in lung cancer cells--study of structure-activity relationship. Toxicol. In Vitro 23: 1047–1054. doi: 10.1016/j.tiv.2009.06.008 PubMed DOI
Šmajs D., Cejková D., Micenková L., Lima-Bittencourt C. I., Chartone-Souza E., Šmarda J., Nascimento A. M. A.2012. Human Escherichia coli strains of different geographical and time source: bacteriocin types and their gene sequences are population-specific. Environ. Microbiol. Rep. 4: 459–466. doi: 10.1111/j.1758-2229.2012.00365.x PubMed DOI
Šmajs D., Micenková L., Šmarda J., Vrba M., Sevčíková A., Vališová Z., Woznicová V.2010. Bacteriocin synthesis in uropathogenic and commensal Escherichia coli: colicin E1 is a potential virulence factor. BMC Microbiol. 10: 288. doi: 10.1186/1471-2180-10-288 PubMed DOI PMC
Šmajs D., Strouhal M., Matejková P., Cejková D., Cursino L., Chartone-Souza E., Šmarda J., Nascimento A. M. A.2008. Complete sequence of low-copy-number plasmid MccC7-H22 of probiotic Escherichia coli H22 and the prevalence of mcc genes among human E. coli. Plasmid 59: 1–10. doi: 10.1016/j.plasmid.2007.08.002 PubMed DOI
Štaudová B., Micenková L., Bosák J., Hrazdilová K., Slaninková E., Vrba M., Ševčíková A., Kohoutová D., Woznicová V., Bureš J., Šmajs D.2015. Determinants encoding fimbriae type 1 in fecal Escherichia coli are associated with increased frequency of bacteriocinogeny. BMC Microbiol. 15: 201. doi: 10.1186/s12866-015-0530-5 PubMed DOI PMC
Stock I., Rahman M., Sherwood K. J., Wiedemann B.2005. Natural antimicrobial susceptibility patterns and biochemical identification of Escherichia albertii and Hafnia alvei strains. Diagn. Microbiol. Infect. Dis. 51: 151–163. doi: 10.1016/j.diagmicrobio.2004.10.008 PubMed DOI
Švec P., Nováková D., Zácková L., Kukletová M., Sedlácek I.2008. Evaluation of (GTG)5-PCR for rapid identification of Streptococcus mutans. Antonie van Leeuwenhoek 94: 573–579. doi: 10.1007/s10482-008-9275-6 PubMed DOI
Švec P., Černohlávková J., Busse H. J., Vojtková H., Pantůček R., Cnockaert M., Mašlaňová I., Králová S., Vandamme P., Sedláček I.2015. Classification of strain CCM 4446T as Rhodococcus degradans sp. nov. Int. J. Syst. Evol. Microbiol. 65: 4381–4387. doi: 10.1099/ijsem.0.000584 PubMed DOI
Valentiner-Branth P., Steinsland H., Fischer T. K., Perch M., Scheutz F., Dias F., Aaby P., Mølbak K., Sommerfelt H.2003. Cohort study of Guinean children: incidence, pathogenicity, conferred protection, and attributable risk for enteropathogens during the first 2 years of life. J. Clin. Microbiol. 41: 4238–4245. doi: 10.1128/JCM.41.9.4238-4245.2003 PubMed DOI PMC
Walk S. T., Alm E. W., Gordon D. M., Ram J. L., Toranzos G. A., Tiedje J. M., Whittam T. S.2009. Cryptic lineages of the genus Escherichia. Appl. Environ. Microbiol. 75: 6534–6544. doi: 10.1128/AEM.01262-09 PubMed DOI PMC
Wang H., Li Q., Bai X., Xu Y., Zhao A., Sun H., Deng J., Xiao B., Liu X., Sun S., Zhou Y., Wang B., Fan Z., Chen X., Zhang Z., Xu J., Xiong Y.2016. Prevalence of eae-positive, lactose non-fermenting Escherichia albertii from retail raw meat in China. Epidemiol. Infect. 144: 45–52. doi: 10.1017/S0950268815001120 PubMed DOI PMC
Yamamoto D., Hernandes R. T., Liberatore A. M. A., Abe C. M., Souza R. B., Romão F. T., Sperandio V., Koh I. H., Gomes T. A. T.2017. Escherichia albertii, a novel human enteropathogen, colonizes rat enterocytes and translocates to extra-intestinal sites. PLOS ONE 12: e0171385. doi: 10.1371/journal.pone.0171385 PubMed DOI PMC
Yamamoto S., Terai A., Yuri K., Kurazono H., Takeda Y., Yoshida O.1995. Detection of urovirulence factors in Escherichia coli by multiplex polymerase chain reaction. FEMS Immunol. Med. Microbiol. 12: 85–90. doi: 10.1111/j.1574-695X.1995.tb00179.x PubMed DOI
Young V. B., Knox K. A., Schauer D. B.2000. Cytolethal distending toxin sequence and activity in the enterohepatic pathogen Helicobacter hepaticus. Infect. Immun. 68: 184–191. doi: 10.1128/IAI.68.1.184-191.2000 PubMed DOI PMC